EXPERIENCE WITH A HISTOSCANNING APPARATUS USED IN THE EARLY DIAGNOSIS OF PROSTATE CANCER
https://doi.org/10.17650/1726-9776-2012-8-1-872-878
Abstract
In September 2011, the Research Institute of Uronephrology and Human Reproductive Health began to use an apparatus for the early diagnosis of prostate cancer. One hundred and fifty-six studies have been conducted by now. In the examinees, the level of prostate-specific antigen was estimated to be in the range of 1.09 to 209 ng/ml. The results of the studies confirm European data on the sensitivity and specificity of this procedure.
About the Authors
P. V. GlybochkoRussian Federation
Yu. G. Alyaev
Russian Federation
A. V. Amosov
Russian Federation
G. E. Krupinov
Russian Federation
A. A. Obukhov
Russian Federation
T. M. Ganzha
Russian Federation
N. A. Amosov
Russian Federation
References
1. Болезни предстательной железы. Под ред. Ю.Г. Аляева. ГЭОТАР-Медиа, 2009.
2. Вестник Российского онкологического научного центра им. Н.Н. Блохина РАМН. Под ред. М.И. Давыдова и Е.М. Аксель. 2006. Т. 17, № 3 (прил. 1); с. 28−30.
3. EAU, Guidelines, 2011.
4. Аляев Ю.Г., Амосов А.В., Винаров А.З. и др. Трансректальная допплерография у больных с заболеваниями предстательной железы. ФГУИПП «Кострома», 2004. 88 с.
5. National Institute for Health and Clinical Excellence (NICE) clinical guideline 58, Prostate Cancer: diagnosis and treatment, 2008.
6. Braeckman J., Autier P., Zaťura F. et al. Evaluation of HistoScanning™ for the detection, location and volume estimation of prostate cancer: Results of the open phase of the PHS-02 study. J Clin Oncol 2011;29 (suppl 7; abstr 55).
7. Степанов В.Н., Франк Г.А., Дисноев Р.Р. Интраэпителиальная неоплазия простаты. Урол и нефрол 1999;1:16−9.
Review
For citations:
Glybochko P.V., Alyaev Yu.G., Amosov A.V., Krupinov G.E., Obukhov A.A., Ganzha T.M., Amosov N.A. EXPERIENCE WITH A HISTOSCANNING APPARATUS USED IN THE EARLY DIAGNOSIS OF PROSTATE CANCER. Cancer Urology. 2012;8(1):72-76. (In Russ.) https://doi.org/10.17650/1726-9776-2012-8-1-872-878